Background illustration for clinical trials search

Paid Clinical Trials Buffalo

Discover 779 paid clinical trials in Buffalo, New York. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.

Filter
2

Open-Label Study of mRNA-3927 in Participants With Propionic Acidemia

for
Propionic Acidemia
Location: Toronto, Ann Arbor MI, Philadelphia PA, New York NY,
Sponsor: ModernaTX, Inc.

Sex: All

Age: 0+

Code: NCT04159103

Phase 1, Phase 2, Recruiting

Substudy 01A: Zilovertamab Vedotin in Pediatric and Young Adult Participants With Hematologic Malignancies or Solid Tumors (MK-9999-01A/LIGHTBEAM-U01)

for
B-cell Acute Lymphoblastic Leukemia,
Location: Toronto, Philadelphia PA, New Brunswick NJ, Valhalla NY,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 0 - 25

Code: NCT06395103

Phase 1, Phase 2, Recruiting

The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study

for
Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia,
Location: Toronto, London, Syracuse NY, Cleveland OH,
Sponsor: PedAL BCU, LLC

Sex: All

Age: 0 - 22

Code: NCT04726241

Phase 1, Phase 2, Recruiting

Non-Invasive Diagnosis of Pediatric Pulmonary Invasive Mold Infections

for
Pulmonary Invasive Fungal Infections,
Location: Toronto, Philadelphia PA, Washington DC, New York NY,
Sponsor: Arkansas Children's Hospital Research Institute

Sex: All

Age: 0 - 21

Code: NCT03827694

Recruiting

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

for
NonSegmental Vitiligo
Location: Toronto, Rochester NY, Waterford MI, Ottawa,
Sponsor: Incyte Corporation

Sex: All

Age: 2 - 11

Code: NCT06548360

Phase 3, Recruiting

Interested in new trials?

Get alerts for new trials in your area by subscribing now

Subscriber Image

Study of Lurbinectedin Monotherapy in Pediatric and Young Adult Participants With Relapsed/Refractory Ewing Sarcoma

for
Refractory Ewing Sarcoma, Relapsed Ewing Sarcoma, Ewing Sarcoma
Location: Toronto, Baltimore MD, Philadelphia PA,
Sponsor: Jazz Pharmaceuticals

Sex: All

Age: 2 - 30

Code: NCT05734066

Phase 1, Phase 2, Recruiting

Pancreatic Cancer Early Detection Consortium

for
Pancreas Cancer, Pancreas Cyst,
Location: Toronto, Rochester NY, Pittsburgh PA, Royal Oak MI,
Sponsor: Arbor Research Collaborative for Health

Sex: All

Age: 18 - 70+

Code: NCT04970056

Recruiting

A Long-Term Study of Elafibranor in Adult Participants With Primary Biliary Cholangitis

for
Primary Biliary Cholangitis (PBC)
Location: Toronto, Pittsburgh PA, Ann Arbor MI, New York NY,
Sponsor: Ipsen

Sex: All

Age: 18+

Code: NCT06016842

Phase 3, Recruiting

Prospective Multicenter Research on Donor and Recipient Management Strategies to Improve Lung Transplant Outcomes

for
Lung Transplant; Complications,
Location: Toronto, Pittsburgh PA, Ann Arbor MI, Baltimore MD,
Sponsor: Duke University

Sex: All

Age: 18+

Code: NCT06399302

Recruiting

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

for
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia,
Location: Toronto, Philadelphia PA, New York NY, Columbus OH,
Sponsor: Syndax Pharmaceuticals

Sex: All

Age: 0+

Code: NCT04065399

Phase 1, Phase 2, Recruiting

Trifecta-Lung cfDNA-MMDx Study

for
Lung Transplantation
Location: Toronto, Baltimore MD, New York NY, Columbus OH,
Sponsor: University of Alberta

Sex: All

Age: 18+

Code: NCT05837663

Recruiting

A Registry for People With Lung Cancer

for
Lung Cancer, Lung Cancer Stage I
Location: Toronto, Pittsburgh PA, Ann Arbor MI, Basking Ridge NJ,
Sponsor: Memorial Sloan Kettering Cancer Center

Sex: All

Age: 18+

Code: NCT06424327

Recruiting

MAGNITUDE: A Phase 3 Study of NTLA-2001 in Participants With Transthyretin Amyloidosis With Cardiomyopathy (ATTR-CM)

for
Transthyretin Amyloidosis (ATTR) With Cardiomyopathy
Location: Toronto, Cleveland OH, Pittsburgh PA, Ann Arbor MI,
Sponsor: Intellia Therapeutics

Sex: All

Age: 18 - 70+

Code: NCT06128629

Phase 3, Recruiting

A Study to Investigate the Safety and Efficacy of GSK4532990 Compared With Placebo in Adult Participants Aged 18 to 70 Years With Alcohol-related Liver Disease

for
Liver Diseases, Alcoholic
Location: Toronto, London, Cleveland OH, Detroit MI,
Sponsor: GlaxoSmithKline

Sex: All

Age: 18 - 70

Code: NCT06613698

Phase 2, Recruiting

Ivosidenib in Participants With Locally Advanced or Metastatic Conventional Chondrosarcoma Untreated or Previously Treated With 1 Systemic Treatment Regimen

for
Locally Advanced or Metastatic Conventional Chondrosarcoma With an IDH1 Mutation, Untreated or Previously Treated With 1 Systemic Treatment Regimen,
Location: Toronto, Cleveland OH, Pittsburgh PA, Baltimore MD,
Sponsor: Servier Bio-Innovation LLC

Sex: All

Age: 18+

Code: NCT06127407

Phase 3, Recruiting

A Study of Nipocalimab in Pregnancies at Risk for Severe Hemolytic Disease of the Fetus and Newborn (HDFN)

for
Hemolytic Disease of the Fetus and Newborn
Location: Toronto, Allentown PA, Baltimore MD, New York NY,
Sponsor: Janssen Research & Development, LLC

Sex: Female

Age: 18 - 45

Code: NCT05912517

Phase 3, Recruiting

Predictors of Pregnancy Outcome in Systemic Lupus Erythematosus (SLE) and Antiphospholipid Syndrome (APS)

for
Systemic Lupus Erythematosus, Antiphospholipid Syndrome
Location: Toronto, New York NY, Salt Lake City UT
Sponsor: Hospital for Special Surgery, New York

Sex: Female

Age: 18 - 45

Code: NCT00198068

Recruiting

A Study of Tucatinib With Trastuzumab and mFOLFOX6 Versus Standard of Care Treatment in First-line HER2+ Metastatic Colorectal Cancer

for
Colorectal Neoplasms
Location: Toronto, Erie PA, Butler PA, Beaver PA, Pittsburgh PA,
Sponsor: Seagen, a wholly owned subsidiary of Pfizer

Sex: All

Age: 18+

Code: NCT05253651

Phase 3, Recruiting

Abatacept for the Treatment of Giant Cell Arteritis

for
Giant Cell Arteritis
Location: Toronto, Cleveland OH, Philadelphia PA, New York NY,
Sponsor: University of Pennsylvania

Sex: All

Age: 50+

Code: NCT04474847

Phase 3, Recruiting

Long-term Safety and Efficacy Extension Study for Participants With Advanced Tumors Who Are Currently on Treatment or in Follow-up in a Pembrolizumab (MK-3475) Study (MK-3475-587/KEYNOTE-587)

for
Solid Tumors, Hematologic Malignancies
Location: Toronto, Kingston, Pittsburgh PA, Detroit MI, Ottawa,
Sponsor: Merck Sharp & Dohme LLC

Sex: All

Age: 18+

Code: NCT03486873

Phase 3, Recruiting